Literature DB >> 8485471

Calcium binding site mutants of calmodulin adopt abnormal conformations in complexes with model target peptides.

P Mukherjea1, K Beckingham.   

Abstract

We have examined the ability of two series of calcium binding site mutants of Drosophila calmodulin to form complexes with the model target peptides melittin and mastoparan. Unlike the wild-type complex, the 1:1 protein:melittin complexes formed by mutants of the C-terminal sites are unable to bind a second molecule of melittin. In contrast, a site 2 mutant shows increased ability to bind two molecules of melittin. For the shorter peptide mastoparan, most mutants form aberrant complexes that are best interpreted in terms of a model in which mastoparan interacts with both terminal domains of calmodulin. For two of the target enzymes of calmodulin, the three mutants which form mastoparan complexes most similar to the wild-type complex are also the best enzyme activators.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8485471

Source DB:  PubMed          Journal:  Biochem Mol Biol Int        ISSN: 1039-9712


  4 in total

1.  Ca2+/calmodulin-dependent protein kinase II (CaMKII) is activated by calmodulin with two bound calciums.

Authors:  Julia M Shifman; Mee H Choi; Stefan Mihalas; Stephen L Mayo; Mary B Kennedy
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-11       Impact factor: 11.205

2.  Interlobe communication in multiple calcium-binding site mutants of Drosophila calmodulin.

Authors:  P Mukherjea; J F Maune; K Beckingham
Journal:  Protein Sci       Date:  1996-03       Impact factor: 6.725

3.  Characterization of novel calmodulin-binding peptides with distinct inhibitory effects on calmodulin-dependent enzymes.

Authors:  L T Nevalainen; T Aoyama; M Ikura; A Crivici; H Yan; N H Chua; A C Nairn
Journal:  Biochem J       Date:  1997-01-01       Impact factor: 3.857

4.  EF hands at the N-lobe of calmodulin are required for both SK channel gating and stable SK-calmodulin interaction.

Authors:  Weiyan Li; David B Halling; Amelia W Hall; Richard W Aldrich
Journal:  J Gen Physiol       Date:  2009-09-14       Impact factor: 4.086

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.